Anti-idiotype isolation of a broad and potent influenza A virus-neutralizing human antibody

Front Immunol. 2024 May 30:15:1399960. doi: 10.3389/fimmu.2024.1399960. eCollection 2024.

Abstract

The VH6-1 class of antibodies includes some of the broadest and most potent antibodies that neutralize influenza A virus. Here, we elicit and isolate anti-idiotype antibodies against germline versions of VH6-1 antibodies, use these to sort human leukocytes, and isolate a new VH6-1-class member, antibody L5A7, which potently neutralized diverse group 1 and group 2 influenza A strains. While its heavy chain derived from the canonical IGHV6-1 heavy chain gene used by the class, L5A7 utilized a light chain gene, IGKV1-9, which had not been previously observed in other VH6-1-class antibodies. The cryo-EM structure of L5A7 in complex with Indonesia 2005 hemagglutinin revealed a nearly identical binding mode to other VH6-1-class members. The structure of L5A7 bound to the isolating anti-idiotype antibody, 28H6E11, revealed a shared surface for binding anti-idiotype and hemagglutinin that included two critical L5A7 regions: an FG motif in the third heavy chain-complementary determining region (CDR H3) and the CDR L1 loop. Surprisingly, the chemistries of L5A7 interactions with hemagglutinin and with anti-idiotype were substantially different. Overall, we demonstrate anti-idiotype-based isolation of a broad and potent influenza A virus-neutralizing antibody, revealing that anti-idiotypic selection of antibodies can involve features other than chemical mimicry of the target antigen.

Keywords: MEDI8852; VH6-1 class; anti-idiotype; broadly neutralizing antibody; cryo-EM; influenza A virus.

MeSH terms

  • Animals
  • Antibodies, Anti-Idiotypic* / immunology
  • Antibodies, Anti-Idiotypic* / isolation & purification
  • Antibodies, Neutralizing* / immunology
  • Antibodies, Neutralizing* / isolation & purification
  • Antibodies, Viral* / immunology
  • Hemagglutinin Glycoproteins, Influenza Virus* / immunology
  • Humans
  • Immunoglobulin Heavy Chains / chemistry
  • Immunoglobulin Heavy Chains / immunology
  • Influenza A virus* / immunology
  • Influenza, Human / immunology
  • Influenza, Human / virology

Substances

  • Antibodies, Viral
  • Antibodies, Neutralizing
  • Antibodies, Anti-Idiotypic
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Immunoglobulin Heavy Chains

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Vaccine Research Center, an intramural Division of the National Institution of Allergy and Infectious Diseases, NIH, and by federal funds from the National Cancer Institute, NIH, under contract no. 75N910D00024. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science (contract W-31-109-Eng-38). Some of this work was performed at the Simons Electron Microscopy Center and the National Resource for Automated Molecular Microscopy, located at the New York Structural Biology Center, supported by grants from the Simons Foundation (SF349247) and NIH National Institute of General Medical Sciences (GM103310), with additional support from NYSTAR and the New York State Assembly.